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Aims Little is known about the influence of psychological factors on prognosis in implantable cardioverter defibrillator
(ICD) patients. We examined the influence of the distressed personality (Type D) and pre-implantation device con-
cerns on short-term mortality in ICD patients.
Methods
and results
Consecutively implanted ICD patients (N ¼ 371; 79.5% men) completed the Type D Scale and the ICD Patient Con-
cerns questionnaire prior to implantation and were followed up for short-term mortality. The prevalence of Type D
was 22.4%, whereas 34.2% had high levels of ICD concerns. The incidence of mortality was higher in Type D vs. non-
Type D patients [13.3% vs. 4.92%; hazard ratio (HR): 2.74; 95% confidence interval (CI): 1.24–6.03] and in patients
with high vs. low levels of ICD concerns (11.0% vs. 4.5%; HR: 2.38; 95% CI: 1.08–5.23). Type D personality (HR: 2.79;
95% CI: 1.25–6.21) and high levels of ICD concerns (HR: 2.38; 95% CI: 1.06–5.34) remained independent predictors
of mortality in separate analyses, adjusting for sex, age, ICD indication, coronary artery disease, and shocks. Patients
with clustering of both Type D personality and high levels of pre-implantation concerns (HR: 3.86; 95% CI: 1.64–
9.10) had a poorer survival compared with patients with one or none of these risk markers in adjusted analysis.
Shocks during the follow-up period were also associated with mortality (HR: 3.09; 95% CI: 1.36–7.04).
Conclusion Patients with a distressed personality and high levels of pre-implantation device-related concerns had a poorer prog-
nosis, independent of other risk markers including shocks. This subgroup of patients should be identified in clinical
practice and would likely benefit from a combined distress management programme and cardiac rehabilitation.
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Introduction
The implantable cardioverter defibrillator (ICD) has evolved to
therapy of first choice for the treatment of life-threatening arrhyth-
mias both as primary and secondary prophylaxis.1 – 3 Despite the
proven medical benefits of ICD therapy, there is an ongoing
debate as to which criteria to use for risk stratification to identify
patients at high risk for sudden cardiac death (SCD).4 Impaired
ejection fraction, microvolt T-wave alternans, and markers of auto-
nomic nervous system functioning, such as heart rate variability and
baroreflex sensitivity, are some of the candidates that have been
examined. However, SCD is not likely to be the end product of
one mechanism but more likely attributable to a range of pro-
cesses, necessitating the use of multivariable risk modelling and
complex algorithms.4 Psychological factors might also have a
place in such algorithms, provided that they have an independent
prognostic value from standard risk markers.
A growing body of evidence suggests that psychological factors,
including anxiety,5 anger,6 anger-induced T-wave alternans,7 and
depression,8 may influence the onset of ventricular arrhythmias
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in ICD patients. A recent study demonstrated that the clustering of
psychological factors may also elevate this risk, with anxious Type
D patients being more likely to experience a ventricular arrhythmia
during the first year following implantation.9 The latter study found
no main effect for depression, anxiety, or Type D personality.9
Type D personality typifies individuals who experience increased
negative emotions, such as worrying and feeling depressed, in com-
bination with not sharing such negative emotions with others due
to fear of their reaction and ultimate rejection.9
Studies examining the role of psychological factors as risk factors
for mortality in ICD patients are scarce, despite factors such as
depression,10,11 anxiety,12,13 and Type D personality14– 16 being
associated with increased risk of mortality in patients with both
coronary artery disease (CAD) and heart failure. To our knowl-
edge, only three studies have examined the role of psychological
factors as determinants of mortality in patients treated with ICD
therapy, with these studies demonstrating an increased risk associ-
ated with the psychosocial status of the patient.17–19
The objective of the current study was to examine the influence
of Type D personality and ICD patient concerns at the time of
implantation on mortality in a cohort of consecutively implanted
ICD patients.
Methods
Patients and study design
The study cohort consisted of consecutive patients who received a
first-time ICD (N ¼ 371; 79.5% men; mean age ¼ 57.7+12.0 years)
between August 2003 and December 2008 at the Erasmus Medical
Center, Rotterdam, The Netherlands. All patients were enrolled in
the Mood and personality as precipitants of arrhythmia in patients
with an Implantable cardioverter Defibrillator: A prospective Study
(MIDAS). Patients with a life expectancy of ,1 year, on the waiting
list for heart transplantation, with a history of psychiatric illness
other than affective/anxiety disorders, or with insufficient knowledge
of the Dutch language were excluded from the study. The MIDAS
study was approved by the medical ethics committee of the Erasmus
Medical Center. The study was conducted according to the ethical
guidelines of the Helsinki Declaration, as set out by the World
Medical Association. All patients provided written informed consent.
Procedure
An ICD nurse approached all patients for participation in the study and
asked them to complete a set of standardized and validated psycho-
logical questionnaires at baseline (i.e. 1 day prior to ICD implantation).
Information on demographic and clinical characteristics were also gath-
ered at baseline; information on demographics, smoking status, and
prescription of psychotropic medication were either assessed by
means of purpose-designed questions in the baseline questionnaire
or derived from the patients’ medical records. Information on clinical
variables was obtained from the patients’ medical records.
Measures
Baseline demographic and clinical variables
Demographic variables included gender, age, marital status, and edu-
cation. Information on clinical variables included indication for ICD
therapy (primary vs. secondary), cardiac resynchronization therapy,
QRS . 120 ms, left ventricular ejection fraction (LVEF), CAD, pre-
vious myocardial infarction (MI), previous percutaneous coronary
intervention, previous coronary artery bypass graft surgery, heart
failure, atrial fibrillation, diabetes mellitus, smoking, cardiac (i.e. amio-
darone, b-blockers, diuretics, angiotensin-converting enzyme inhibi-
tors, statins, and digoxin) and psychotropic medication.
Psychological assessments
Type D personality
Type D personality was assessed with the 14-item Type D Scale
(DS14),20 which was administered at baseline. The DS14 assesses
two personality traits, namely negative affectivity (e.g. ‘I often feel
unhappy’; seven items) and social inhibition (e.g. ‘I am a closed kind of
person’; seven items). Items are answered on a five-point Likert scale
ranging from 0 (false) to 4 (true), with a score range from 0 to 28
for both subscales.20 Patients with a Type D personality are typified
by a high score on both negative affectivity and social inhibition, as
determined by a standardized cut-off ≥10 on both subscales.20,21
The DS14 is a valid and reliable measure, with a good internal consist-
ency, as shown by Cronbach’s a of 0.88/0.86 and 3-month test-retest
reliability of r ¼ 0.72/0.82 for the negative affectivity and social inhi-
bition subscales, respectively.20 The DS14 was originally developed
in cardiac patients and identifies patients with a high risk for morbidity
and mortality, independent of standard risk factors and mood states,
such as anxiety and depression.22 It is the combination of the two
traits, negative affectivity and social inhibition rather than the single
traits that incurs an increased risk of poor prognosis.15 The DS14
has shown to be a stable measure during an 18-month period in
post-MI patients23 and to be unconfounded by indicators of somatic
disease, including left ventricular (LV) dysfunction, and measures of
anxiety and depression.23,24
Pre-implantation device-related concerns
The eight-item ICD Patient Concerns questionnaire (ICDC) was admi-
nistered at baseline to assess device-related concerns as reported by
the patient.25 The ICDC was originally developed in the UK26 and
later adapted and abbreviated for the Dutch setting.25 Patients rate
the items (e.g. ‘I am worried about my ICD firing’ and ‘I am worried
about symptoms/pain associated with my ICD firing’) on a five-point
Likert scale from 0 (not at all) to 4 (very much so). All items are
summed together in a total score (score range from 0 to 32), with a
higher score indicating more device-related concerns.25 As there is
no standardized cut-off for the ICDC, we divided patients into a
high vs. low concern group, using the highest tertile (cut-off ≥13) to
indicate a high level of concerns. The internal consistency of the eight-
item ICDC is good, as demonstrated by a Cronbach’s a ¼ 0.91.25
Delivered implantable cardioverter defibrillator therapy
during follow-up
Recording of delivered ICD therapy started from the time of ICD
implantation. All patients were followed at 3-month intervals and
were advised to contact our outpatient clinic following a symptomatic
event as soon as possible. Two experienced electrophysiologists from
the electrophysiology staff of the Erasmus Medical Center reviewed
and categorized all spontaneous episodes with stored electrograms
that resulted in ventricular therapies. If the two reviewers disagreed
about the stored electrograms, a third reviewer was consulted and a
consensus was reached. For each episode, the date, type, and mean
cycle length of the tachyarrhythmia, and the type and outcome of
delivered ICD therapy were recorded. The arrhythmias were classified
as (i) ventricular tachyarrhythmia or (ii) atrial tachyarrhythmia without
a coexistent ventricular arrhythmia. Therapy triggered by ventricular
tachyarrhythmias was considered appropriate, whereas therapy deliv-
ered for atrial tachyarrhythmias (including atrial fibrillation, atrial










flutter, atrial tachycardia, and sinus tachycardia) or T-wave oversensing
and noise was categorized as inappropriate.
Endpoint
The endpoint was defined as mortality (all-cause), with the mean
follow-up period being 1.7+0.5 years (median follow-up ¼ 2 years;
range ¼ 47 days to 2 years). No patients were lost to follow-up. Infor-
mation on mortality was obtained from the patients’ medical records.
Statistical analysis
Patients who died during the follow-up period were compared with
survivors using the x2 test (Fisher’s exact test when appropriate) for
nominal variables and Student’s t-test for continuous variables.
Kaplan–Meier curves were generated to compare the risk of mortality
stratified by group (i.e. Type D vs. non-Type D personality and high vs.
low ICD concerns). Univariable and multivariable Cox’s proportional
hazard regression analyses were used to examine the influence of
the psychological risk markers (i.e. Type D personality and high
levels of ICD concerns) and their clustering on mortality. As rec-
ommended by others,27 we selected our covariates for the multivari-
able models a priori based on the literature and decided to adjust for
sex, age, ICD indication, aetiology, and shocks (appropriate or inap-
propriate) during the follow-up period. For the results of the Cox pro-
portional hazard models, hazard ratios (HRs) and their corresponding
95% confidence intervals (CIs) are reported. All data were analysed
using SPSS 17.0 for Windows (SPSS Inc., Chicago, IL, USA). All tests
were two-tailed, and a P-value of ,0.05 was used to indicate statistical
significance.
Results
Participants vs. non-participants on
baseline characteristics
Of 391 patients implanted with an ICD, 20 (5.1%) patients either
refused to participate in the study or did not have sufficient data
on either the Type D Scale or the ICDC to calculate a valid
score on the questionnaire. Hence, analyses were based on 371
patients. The 20 patients excluded from analyses were more
likely to have a history of atrial fibrillation (55.0 vs. 23.2%; P ¼
0.003) and to have had a recent MI (30.0% vs. 6.2%; P ¼ 0.002),
but less likely to be prescribed diuretics (30.0% vs. 56.1%; P ¼
0.04), compared with the 371 patients included in the analyses.
No other statistically significant differences were found between
the two groups on demographic and clinical baseline
characteristics.
Patient baseline characteristics
Patient baseline characteristics for the total sample and stratified
by survival status are shown in Table 1. During follow-up, 25 of
371 (6.7%) patients died. Patients who died during the follow-up
period were more likely to be older, to have CAD, a previous
MI, a Type D personality, score high on ICD concerns, and to
experience more ICD shocks (both appropriate and inappropriate)
during follow-up (all Ps , 0.05). No other statistically significant
differences were found between the two groups on demographic
and clinical baseline characteristics, including cardiac and psycho-
tropic medication.
Type D and non-Type D patients, and patients with high vs. low
levels of pre-implantation ICD concerns, did not differ systemati-
cally on the majority of demographic and clinical characteristics.
The only exceptions were that Type D patients were less likely
to have a partner (12.0 vs. 4.9%; P ¼ 0.04) and more likely to
take psychotropic medication (26.5 vs. 14.3%; P ¼ 0.015) than
non-Type D patients. Patients with high levels of pre-implantation
ICD concerns were less likely to have heart failure (31.5 vs. 43.4%;
P ¼ 0.034) and more likely to take psychotropic medication (24.6
vs. 13.2%; P ¼ 0.009) than patients with low levels of pre-
implantation ICD concerns. The length of follow-up did not
differ significantly between Type D and non-Type D patients
(603+196 vs. 606+ 194 days; P ¼ 0.91), nor between patients
with high vs. low levels of pre-implantation ICD concerns
(616+185 vs. 599+ 199 days; P ¼ 0.42). Similarly, the number
of patients receiving a shock (both appropriate and inappropriate)
during the follow-up period did not differ between Type D and
non-Type D patients (19.3% vs. 18.8%; P ¼ 1.00), nor between
patients with high vs. low pre-implantation ICD concerns (19.7%
vs. 18.4%; P ¼ 0.88).
Type D personality, pre-implantation
implantable cardioverter defibrillator
concerns, and survival
Of all patients, 22.4% had a Type D personality and 34.2% had high
levels of ICD concerns. At follow-up, the incidence of mortality
was higher in patients with a Type D personality (13.3% vs.
4.9%; HR: 2.74; 95% CI: 1.24–6.03; P ¼ 0.01) and high ICD con-
cerns (11.0% vs. 4.5%; HR: 2.38; 95% CI: 1.08–5.23; P ¼ 0.03).
Kaplan-Meier curves for the time to mortality stratified by Type
D personality and high levels of ICD concerns are shown in
Figure 1. The unadjusted HRs associated with the respective
psychological factors are reported above the Kaplan-Meier curves.
In multivariable analysis, Type D personality (HR: 2.79; 95% CI:
1.25–6.21; P ¼ 0.01) remained an independent predictor of mor-
tality, adjusted for gender, age, ICD indication, CAD, and shock
(both appropriate and inappropriate) during the follow-up period
(Table 2). Any ICD shock during follow-up was also associated
with an increased risk of mortality at follow-up (HR: 3.00; 95%
CI: 1.31–6.88; P ¼ 0.01). Similarly, in adjusted analysis, high levels
of pre-implantation ICD concerns were associated with a more
than two-fold increased risk for mortality (HR: 2.38; 95 % CI:
1.06–5.34; P ¼ 0.04) (Table 2). Shock during follow-up was
again associated with poor survival (HR: 2.92; 95 % CI: 1.29–
6.59; P ¼ 0.01).
Clustering of psychological risk markers
Given that both Type D personality and high levels of pre-
implantation ICD concerns were independently associated with
mortality, in secondary analysis, we examined the influence of
the clustering of these two psychological risk markers in individual
patients on mortality. As shown in Figure 2, the incidence of mor-
tality was significantly higher in patients with both Type D person-
ality and high pre-implantation concerns (18.2% vs. 5.2%; P ¼
0.005). The risk for mortality in patients with the clustering of
these two risk markers remained both statistically significant and










clinically relevant, with the risk being close to four-fold (HR: 3.86;
95% CI: 1.64–9.10; P ¼ 0.002), adjusting for gender, age, ICD indi-
cation, CAD, and shock (both appropriate and inappropriate)
during the follow-up period. The occurrence of any ICD shock
during the follow-up period was also an independent predictor
of mortality (HR: 3.09; 95% CI: 1.36–7.04; P ¼ 0.007).
Discussion
The objective of the current study was to examine the influence of
Type D personality and pre-implantation device-related concerns
on mortality in a cohort of consecutively implanted ICD patients.
We found that the psychological profile of the patient both had
a statistically significant but also a clinically relevant impact on
short-term survival, despite state-of-the-art treatment with ICD
therapy. The risk of poor prognosis was enhanced by two-fold in
patients with high levels of pre-implantation concerns or a dis-
tressed personality, whereas the risk in patients with clustering
of both psychological risk markers increased to close to four-fold
compared with patients with only one or none of these markers.
The risk associated with the psychological factors was independent
of any ICD shock during follow-up, ICD indication, CAD, gender,
and age. To our knowledge, to date, only three studies in ICD
patients have examined whether psychological factors and patient-
reported quality of life impact on survival.17–19 Two of these
studies were subanalyses of the second Multicenter Automatic
Defibrillator Implantation Trial (MADIT II)19 and the Antiarrhyth-
mics Versus Implantable Defibrillators (AVID) trial.18 Both
studies confirmed an impact of patient-reported quality of life
and the patient’s psychosocial status on survival. In a prospective
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Table 1 Patient baseline characteristics for the total sample and stratified by mortality a median of 2 years
post-implantation
Characteristics Total (N 5 371) Dead (n 5 25) Alive (n 5 346) P-value
Demographics
Women 76 (20.5%) 5 (20.0%) 71 (20.5%) 1.00
Age (mean+ SD) 57.7+12.0 63.3+10.6 57.3+12.1 0.02
Single/no partner 24 (6.5%) 2 (8.0%) 22 (6.4%) 0.67
Lower educationa 215 (58.9%) 18 (72.0%) 197 (57.9%) 0.24
Clinical
Primary prevention indication 237 (63.9%) 12 (48.0%) 225 (65.0%) 0.14
CRT 105 (28.3%) 11 (44.0%) 94 (27.2%) 0.12
Shocks during follow-upb 70 (18.9%) 11 (44.0%) 59 (17.1%) 0.002
QRS . 120 ms 192 (51.8%) 18 (72.0%) 174 (50.3%) 0.06
LVEF ≤ 35%c 274 (87.0%) 18 (90.0%) 256 (86.8%) 1.00
CAD 216 (58.2%) 20 (80.0%) 196 (56.6%) 0.04
Previous MI 186 (50.1%) 19 (76.0%) 167 (48.3%) 0.02
Previous PCI 93 (25.1%) 9 (36.0%) 84 (24.3%) 0.29
Previous CABG 76 (20.5%) 7 (28.0%) 69 (20.0%) 0.48
Heart failure 146 (39.4%) 14 (56.0%) 132 (38.2%) 0.12
Atrial fibrillation 86 (23.2%) 7 (28.0%) 79 (22.8%) 0.73
Diabetes 55 (14.9) 7 (28.0%) 48 (14.0%) 0.08
Smoking 43 (11.6%) 0 (0.0%) 43 (12.5%) 0.10
Medication
Amiodarone 70 (18.9%) 7 (28.0%) 63 (18.2%) 0.35
b-blockers 293 (79.0%) 20 (80.0%) 273 (78.9%) 1.00
Diuretics 208 (56.1%) 18 (72.0%) 190 (54.9%) 0.15
ACE-inhibitors 260 (70.1%) 18 (72.0%) 242 (69.9%) 1.00
Statins 210 (56.6%) 14 (56.0%) 196 (56.6%) 1.00
Digoxin 60 (16.2%) 5 (20.0%) 55 (15.9%) 0.80
Psychotropic medication 63 (17.1%) 5 (20.0%) 58 (16.9%) 0.78
Psychological
Type D personality 83 (22.4%) 11 (44.0%) 72 (20.8%) 0.02
Pre-implantation ICD concernsd 127 (34.2%) 14 (56.0%) 113 (32.7%) 0.03
Results are presented as n (%) unless otherwise indicated. CABG, coronary artery bypass graft surgery; CAD, coronary artery disease; CRT, cardiac resynchronization therapy;
ICD, implantable cardioverter defibrillator; LVEF, left ventricular ejection fraction; MI, myocardial infarction; PCI, percutaneous coronary intervention.
aLess than or equal to 13 years.
bAppropriate or inappropriate shocks.
cInformation on assessment of left ventricular function, either by means of echocardiography, nuclear imaging, or angiography was available for 84.9% (315/371) of the patients.
dCut-off ≥13 on the ICD Concerns questionnaire.










cohort study of ICD patients, Ladwig et al.17 demonstrated that the
development of post-traumatic stress in ICD patients also has an
impact on survival.
Previously, studies in patients with acute coronary syndrome
and heart failure have indicated that Type D personality is associ-
ated with a two- to four-fold increased risk of mortality indepen-
dent of traditional risk factors and indicators of disease severity,
including LV dysfunction and New York Heart Association
(NYHA) functional class.14– 16 A recently published study demon-
strated that Type D personality also increases the risk of adverse
clinical outcome in patients treated with ICD therapy.9 In the
latter study, anxious patients with a Type D personality (i.e.
patients with both a Type D personality and high levels of
anxiety) had a higher risk for ventricular arrhythmia. The results
of the current study extend these findings, by showing that Type
D, and the clustering of pre-implantation ICD concerns and
Type D, is also related to poorer survival. Rozanski et al.28 has pre-
viously emphasised the importance of studying the influence of
clustering of psychosocial risk factors, as the tendency is to study
single risk factors, which is less likely to capture the real risk
factor burden to individual patients.
In the current study, we also found that shock during the
follow-up period was associated with increased risk for mortality.
This finding concurs with the results of subanalyses of the
MADIT-II and the Sudden Cardiac Death in Heart Failure Trial
(SCD-HeFT), which have also demonstrated that shock may be
associated with poor survival.29,30 As shown in SCD-HeFT by
Poole et al.,29 the association between ICD shocks and survival
may in part be attributed to the progression of heart failure, but
their results also showed that inappropriate ICD shocks were
associated with an increased risk of mortality.
Given that psychological factors impact on survival in patients
treated with ICD therapy and carry unique predictive value
above and beyond standard biomedical risk factors, as demon-
strated here and in other studies,17–19 it is important to assess
and monitor the psychological status of patients in clinical practice.
Paradoxically, these factors are not assessed standardly, nor can a
proxy be derived from traditional biomedical factors routinely
Figure 1 Kaplan-Meier curves for the time to mortality strati-
fied by (A) Type D personality and (B) high levels of ICD
concerns.
Figure 2 Mortality stratified by the clustering of psychological
risk markers (i.e. Type D personality and high levels of ICD con-
cerns). Total numbers are listed on top of bars.
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Table 2 Type D personality, high levels of
pre-implantation ICD concerns, and survival (adjusted
analysis)
HR 95% CI P-value
Type D personality
Type D personality 2.79 1.25–6.21 0.01
Male sex 0.58 0.21–1.61 0.29
Age 1.03 0.99–1.71 0.20
Primary prevention indication 0.75 0.32–1.74 0.50
CAD 2.31 0.80–6.69 0.12
Shock during follow-upa 3.00 1.31–6.88 0.01
High levels of pre-implantation ICD concerns
Pre-implantation ICD concernsb 2.38 1.06–5.34 0.04
Male sex 0.71 0.25–1.99 0.51
Age 1.04 1.00–1.09 0.08
Primary prevention indication 0.84 0.37–1.91 0.67
CAD 1.99 0.69–5.74 0.20
Shock during follow-upa 2.92 1.29–6.59 0.01
Cox’s proportional hazard regression analysis. CAD, coronary artery disease.
aAppropriate or inappropriate shocks
bCut-off ≥13 on the ICD Concerns questionnaire.










assessed. Hence, they need to be assessed in their own right in
order to optimise the clinical care of ICD patients.
Brief, standardised and validated, disease-specific measures are
available that have been developed specifically to tap symptoms
important to ICD patients, such as the 8-item ICD Patient Con-
cerns questionnaire25 used in the current study, the 10-item
Florida Shock Anxiety Scale,31 and the 18-item Florida Patient
Acceptance Survey.32,33 One of these measures could easily be
used as a screening tool in clinical practice, as it comprises little
burden to patients. Moreover, the physician or the ICD nurse
could use such assessment to discuss more sensitive psychological
issues with patients and their families, which may be particularly
welcome. Importantly, there is evidence to show that ICD patients
derive benefit from psychological and behavioural intervention in
terms of reductions in distress,34–36 which in turn may improve
the quality of life and survival. In other words, we do have some-
thing to offer to ICD patients who are at higher risk for adverse
clinical outcome based on their psychological profile, if we
would only identify this subset of patients in clinical practice.
This study has some limitations. First, the number of clinical
events at follow-up was limited. This reduced the number of cov-
ariates that we could enter in multivariable analysis, as over-fitting
statistical models reduces the power of the study and renders
models unstable.27 Hence, we also did not include partner
status, heart failure, and psychotropic medication, although Type
D/non-Type D patients did differ on partner status and the use
of psychotropic medication, and patients with high vs. low levels
of pre-implantation ICD concerns on the presence of heart
failure and psychotropic medication. However, neither partner
status, nor heart failure, nor psychotropic medication was related
to mortality in univariable analysis (data not shown). Secondly,
we were not able to adjust statistically in multivariable analysis
for LV dysfunction, due to missing information on LV dysfunction
in 56 (15.1%) patients. However, there was no statistically signifi-
cant difference in the proportion of patients with an LVEF of
≤35% experiencing an event during follow-up vs. event-free
patients. Thirdly, we did not have information about the cause of
death, but only about general survival status and the time of
death. Fourthly, we only examined the impact of Type D person-
ality and high levels of pre-implantation concerns on short-term
outcome. In future studies, it will be important to investigate
whether these effects are also present on the long term, although
evidence from Type D research indicates that to be the case in
other cardiac populations, such as acute coronary syndrome,
heart failure, and patients with peripheral arterial disease.22,37
In conclusion, both Type D personality and high pre-
implantation ICD concerns increased the risk for mortality post-
implantation independent of traditional biomedical risk factors
and ICD shock. The risk of poor prognosis was further enhanced
if these two psychological risk markers clustered together within
individual patients, with the associated risk increasing from
two-fold to close to four-fold. This finding indicates that in patients
receiving ICDs, the psychological profile of the patient carries
unique predictive value. This subgroup of high-risk patients
should be identified and monitored in clinical practice and would
likely benefit from a combined distress management programme
and cardiac rehabilitation.35
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